AI assistant
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2019
Mar 1, 2019
32814_dirs_2019-03-01_54942e84-58b4-482f-b755-18238cf35488.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2019-02-28
Reporting Person: TYLE PRAVEEN (EVP, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-28 | Common Stock | M | 2990 | — | Acquired | 5252 | Direct |
| 2019-02-28 | Common Stock | M | 9727 | — | Acquired | 14979 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-28 | Restricted Stock Units | $ | M | 2990 | Disposed | Common Stock (2990) | Direct | |
| 2019-02-28 | Restricted Stock Units | $ | M | 9727 | Disposed | Common Stock (9727) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
F3: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.